Bagchi S, Yuan R, Engleman EG (2021) Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annu Rev Pathol 16:223–249

Article  CAS  PubMed  Google Scholar 

Baranzini SE, Mudge J, Van Velkinburgh JC et al (2010) Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464(7293):1351–1356

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biller LH, Syngal S, Yurgelun MB (2019) Recent advances in Lynch syndrome. Fam Cancer 18(2):211–219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541–550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campesato LF, Barroso-Sousa R, Jimenez L et al (2015) Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice. Oncotarget 6(33):34221–34227

Article  PubMed  PubMed Central  Google Scholar 

Carlino MS, Larkin J, Long GV (2021) Immune checkpoint inhibitors in melanoma. Lancet 398(10304):1002–1014

Article  CAS  PubMed  Google Scholar 

Chen L, Han X (2015) Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest 125(9):3384–3391

Article  PubMed  PubMed Central  Google Scholar 

Forde PM, Spicer J, Lu S et al (2022) Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med 386(21):1973–85

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gross ND, Miller DM, Khushalani NI et al (2022) Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. N Engl J Med 387(17):1557–1568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

Article  CAS  PubMed  Google Scholar 

He D, Wu Z, He J et al (2019) Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis. Gene 696:47–53

Article  CAS  PubMed  Google Scholar 

Hu FF, Liu CJ, Liu LL et al (2021) Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform 22(3):bbaa176

Iyer RR, Pluciennik A, Burdett V et al (2006) DNA mismatch repair: functions and mechanisms. Chem Rev 106(2):302–323

Article  CAS  PubMed  Google Scholar 

Knowles DA, Bouchard G, Plevritis S (2019) Sparse discriminative latent characteristics for predicting cancer drug sensitivity from genomic features. PLoS Comput Biol 15(5):e1006743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74:681–710

Article  CAS  PubMed  Google Scholar 

Lawrence MS, Stojanov P, Mermel CH et al (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505(7484):495–501

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JK, Sivakumar S, Schrock AB et al (2022) Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors. NPJ Precis Oncol 6(1):91

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Fu J, Zeng Z et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509-w14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maglott D, Ostell J, Pruitt KD et al (2011) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 39(Database issue):D52-7

Article  CAS  PubMed  Google Scholar 

Mehdi A, Rabbani SA (2021) Role of Methylation in Pro- and Anti-Cancer Immunity. Cancers (Basel) 13(3):545

Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17(9):559–572

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Connell E, Reynolds IS, Mcnamara DA et al (2020) Microsatellite instability and response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis. Surg Oncol 34:57–62

Article  CAS  PubMed  Google Scholar 

Rahib L, Wehner MR, Matrisian LM et al (2021) Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open 4(4):e214708

Article  PubMed  PubMed Central  Google Scholar 

Saidak Z, Soudet S, Lottin M et al (2021) A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment. Cancer Immunol Immunother 70(4):923–933

Article  CAS  PubMed  Google Scholar 

Schoenfeld AJ, Hellmann MD (2020) Acquired Resistance to Immune Checkpoint Inhibitors. Cancer Cell 37(4):443–455

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348(6230):56–61

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17–48

Article  PubMed  Google Scholar 

Topalian SL (2017) Targeting Immune Checkpoints in Cancer Therapy. JAMA 318(17):1647–1648

Article  PubMed  Google Scholar 

Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27(4):450–461

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vivian J, Rao AA, Nothaft FA et al (2017) Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35(4):314–316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Ngo V, Wang W (2021) Deciphering the genetic code of DNA methylation. Brief Bioinform 22(5):bbaa424

Wei G, Wang J, Huang H et al (2017) Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia. J Hematol Oncol 10(1):150

Article  PubMed  PubMed Central  Google Scholar 

Wu P, Farrell WE, Haworth KE et al (2018) Maternal genome-wide DNA methylation profiling in gestational diabetes shows distinctive disease-associated changes relative to matched healthy pregnancies. Epigenetics 13(2):122–128

Article  PubMed  PubMed Central